Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Key Points
Key points are not available for this paper at this time.
Abstract
National Institute for Health Research Health Technology Assessment Programme.
Like
Bookmark
Share
View Full Paper
Like
Bookmark
Share
View Full Paper
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial | Synapse